The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J07 | Vaccines | |
3
|
J07B | Viral vaccines | |
4
|
J07BH | Rota virus diarrhea vaccines |
| Code | Title | |
|---|---|---|
| J07BH01 | Rota virus, live attenuated | |
| J07BH02 | Rota virus, pentavalent, live, reassorted |
| Active Ingredient |
|---|
|
Rotavirus vaccine is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection. In clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of the most common genotypes G1P [8], G2P [4], G3P [8], G4P [8] and G9P [8]. |
|
|
|
|
|
|
|
|
|
|
| Document | Type | Information Source | |
|---|---|---|---|
| ROTARIX Powder and solvent for oral suspension | MPI, EU: SmPC | European Medicines Agency (EU) |